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ABSTRACT
Objective: This study aimed to examine the effectiveness of Centella asiatica L. as a phytoestrogen.
Methods: Therapy using C. asiatica extract at doses of 60 mg/kg body weight, 120 mg/kg BW, and 180 mg/kg BW was administered to ovariectomized 
rats for 30 days.
Results: Histological examination using hematoxylin and eosin staining demonstrated an increased number of osteocytes and a decreased number of 
osteoclasts, but there was no significant increase in osteoblast numbers.
Conclusion: The administration of the low doses of C. asiatica extract affects the number of osteocytes and osteoclasts but not osteoblasts in 
ovariectomized rats.
Keywords: Centella asiatica, Estrogen, Osteoporosis, Osteocytes, Osteoclasts, Osteoblasts.
INTRODUCTION
Osteoporosis is a bone disease characterized by the reduction in the 
mass density or volume of bones. Reduced mass density could lead to 
the reduction in the mechanical strength of bones such that they are 
more susceptible to fractures [1]. The incidence of osteoporosis has 
been associated with old age, particularly in postmenopausal women, 
and has become a major health problem even in developed countries. 
The bone remodeling process in postmenopausal women significantly 
increases and continues to increase for up to 40 years after the 
cessation of ovarian function, leading to progressive and continuous 
bone resorption. Increased bone activity is probably mediated through 
shorter osteoblast life and prolonged osteoclast life [2].
Hormone replacement is the most effective and only therapy that shows 
significant results in preventing the loss of bone density and reducing the 
risk of fractures [3]. Many women prefer to use phytoestrogens rather 
than estrogen for hormone replacement therapy due to the adverse 
effects of synthetic estrogen, such as increased risk of breast cancer and 
endometrial bleeding. Phytoestrogens are plant-derived chemicals that 
have a similar function to the estrogen hormone naturally produced in 
the body [4]. Numerous plants, including Centella asiatica L., have been 
reported to contain phytoestrogens. C. asiatica is a cosmopolitan plant, 
which indicates its widespread distribution, particularly in the tropics 
and subtropics. It grows well in places with sufficient sunlight as well as 
in shaded places with fertile but rather damp soil.
The phytochemical content of C. asiatica leaf constitutes terpenoids, 
flavonoids, olive oil, and amino acids [5]. The flavonoid groups in 
C. asiatica, which act as phytoestrogens, include quercetin, kaempferol, 
various glycosides, catechins, rutin, naringin, castilliferol, and 
castillicetin [6,7].
Kaempferol, a flavonol derivative of the Kaempferia galanga L. rhizome, 
is a phytoestrogen that can exert osteogenic effects and can also be 
found in C. asiatica. The previous research has shown that kaempferol 
stimulates the osteogenic differentiation of osteoblasts in vitro through 
estrogen receptor signaling [8]. Moreover, quercetin and kaempferol 
show an inhibitory effect on bone resorption and mature osteoclast 
apoptosis [9]. Quercetin, which is also present in C. asiatica, shows a 
significant stimulatory effect on the proliferation and mineralization of 
rat osteoblasts, thus promoting the bone formation process [10].
Other flavonol groups contained in C. asiatica leaves have been 
shown to prolong osteoblasts life and increase alkaline phosphatase 
activity. Reportedly, catechin therapy reduces the production of 
cytokines that induce bone resorption and apoptosis in osteoblasts, 
resulting in the prevention of osteoporosis and inflammatory bone 
disease [11]. Naringin, another flavonoid found in C. asiatica, could 
reduce the number of osteoclasts formed through interleukin (IL)-1-
induced differentiation. Furthermore, naringin increases bone mass by 
suppressing osteoclast formation in rats, thus preventing bone diseases 
such as osteoporosis [12].
This evidence indicates that C. asiatica may prevent postmenopausal 
osteoporosis by reducing the number of osteoclasts and increasing the 
number of osteoblasts.
METHODS
The study protocol had been approved by the Dental Research 
Ethics Committee, Faculty of Dentistry, Universitas Indonesia. This 
was an experimental study using a post-test control group design. 
In total, 30 laboratory rats were randomly assigned to one of the 
six groups: Control rats (SHAM); untreated ovariectomized rats 
(negative control); ovariectomized rats administered C. asiatica leaf 
extract at three different doses (P1=60, P2=120, and P3=180 mg/kg 
body weight [BW]); and ovariectomized rats administered Vitamin 
E (positive control) for 30 days. Histological sections were stained 
with hematoxylin and eosin and were used to calculate the number 
of osteoclasts, osteoblasts, and osteocytes (Fig. 1a-c). Then, the data 
on osteoclast, osteoblast, and osteocyte count were analyzed by the 
Shapiro–Wilk normality test. A non-parametric Kruskal–Wallis test 
was used for the non-homogeneous, non-normal distributed data. The 
significant results of osteoclast and osteocyte data were then analyzed 
by a post hoc Mann–Whitney U-test. Data on the numbers of osteoblast 
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and osteoclast were analyzed by Pearson’s correlation test, and data on 
the number of osteocytes were analyzed by Spearman’s correlation test.
RESULTS
The success of ovariectomy was determined by measuring the trabecular 
bone length of the SHAM and ovariectomized rats. In the same broad 
field of view, the length of the trabecular bone in unovariectomized 
rats was longer than that in the ovariectomized rats, indicating the 
effectiveness of ovariectomy procedure.
K−: Negative control group (aquadest); K+: Positive control group 
(Vitamin E); P1: Treated Group 1 (Centella asiatica, 60 mg/kg BW); 
P2: Treated Group 2 (C. asiatica, 120 mg/kg BW); P3: Treated Group 3 
(C. asiatica, 180 mg/kg BW); *p<0.05.
The results showed a significant decrease in the number of osteoclasts in 
the group administered with C. asiatica extract at doses of 60 mg/kg BW 
(P1) and 120 mg/kg BW (P2) against negative control (p<0.005) (Fig. 2).
K−: Negative control group (aquadest); K+: Positive control group 
(Vitamin E); P1: Treated Group 1 (Centella asiatica, 60 mg/kg BW); 
P2: Treated Group 2 (C. asiatica, 120 mg/kg BW); P3: Treated Group 3 
(C. asiatica, 180 mg/kg BW).
The results showed no significant increase in the number of osteoblasts 
(Fig. 3). However, there was a significant increase in the number of 
osteocytes in the negative control group (K−) administered with 
C. asiatica extract at a dose of 180 mg/kg BW (p<0.005), and a strong 
and significant correlation was observed between the administration 
of C. asiatica leaf extract and increase in the number of osteocytes 
(p<0.005; R=0.756) (Fig. 4).
K−: Negative control group (aquadest); K+: Positive control group 
(Vitamin E); P1: Treated Group 1 (Centella asiatica, 60 mg/kg BW); 
P2: Treated Group 2 (C. asiatica, 120 mg/kg BW); P3: Treated Group 3 
(C. asiatica, 180 mg/kg BW); *p<0.05.
DISCUSSION
Estrogens protect bones by inducing apoptosis in osteoclasts to balance 
the bone formation process by osteoblasts and bone resorption by 
Fig. 1: (a) Histological appearance of osteoclasts in the tibia of 
rats (Stain: Hematoxylin and eosin), (b) Histological appearance 
of osteoblasts in the tibia of rats (Stain: Hematoxylin and eosin) 
(c) Histological appearance of osteocytes in the tibia of rats 




Fig. 2: Average and standard deviation of the number of 
osteoclasts in rats
Fig. 3: Average and standard deviation of the number of 
osteoblasts in rats
Fig. 4: Average and standard deviation of the number of 
osteocytes in rats
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osteoclasts. Many studies have shown that the Fas ligand (FasL) 
receptor plays a role in the process of estrogen-induced osteoclast 
apoptosis through the autocrine activation of the osteoclasts. FasL binds 
estrogen receptor α in osteoclasts, mediating the apoptosis of mature 
osteoclasts [13]. Other theories have posited the presence of paracrine 
mechanisms through which estrogen affects the survival of osteoclasts by 
increasing FasL in osteoblasts and triggering preosteoclast apoptosis [14].
Reportedly, flavonoids contained in C. asiatica initiate bone formation 
and inhibit bone resorption in vitro. Quercetin stimulates osteoblast 
proliferation and osteoclasts apoptosis. Naringin suppresses osteoclast 
number by inhibiting the production of IL-1 cytokine. Kaempferol 
stimulates the osteogenic differentiation of osteoblasts and apoptosis 
of osteoclasts, and catechins inhibit the production of tumor necrosis 
factor-α (TNF-α) and IL-6 cytokines, inhibiting osteoblast apoptosis. 
These findings suggest that C. asiatica can be effective in preventing 
osteoporosis.
Ovariectomy results in the increased production of TNF-α cytokines, 
which mediate osteoclastogenesis induced by receptor activator of 
nuclear factor kappa-Β ligand and macrophage colony-stimulating 
factor, leading to increased osteoclast numbers [15]. Our findings 
demonstrated a significantly reduced osteoclast number in 
ovariectomized rats administered C. asiatica leaf extract at doses of 
60 mg/kg BW and 120 mg/kg BW but not at a dose of 180 mg/kg BW. 
The increased osteoclast number in the groups administered a dose of 
180 mg/kg BW over 30 days indicates that this dosage of C. asiatica 
as a natural source of estrogen is not optimal to inhibit osteoclast 
differentiation despite increased osteoclast numbers. At very high 
doses, flavonoids function as pro-oxidants and allow the accumulation 
of free radicals within the body, thereby increasing oxidative stress that 
causes bone damage [16].
Estrogen deficiency stimulates osteoblast apoptosis and mediates 
oxidative stress in bones and bone marrow, thus accelerating bone 
loss [17]. Reportedly, C. asiatica exerts a protective effect against 
oxidative stress by activating the d-aminolevulinic acid dehydratase 
enzyme, inhibiting lipid peroxidation, and activating antioxidant 
enzymes. Therefore, the use of C. asiatica could prevent osteoblast 
apoptosis, facilitating bone formation. However, C. asiatica therapy 
in this study did not lead to a significant increase in the number of 
osteoblasts in ovariectomized rats, which may be attributed to the short 
duration of the study. The dose-dependent properties of phytoestrogens 
may be another reason for this finding [18]. Other studies of catechin 
administration in ovariectomized rats or 3 months have reported 
increased bone density through increased osteoblast activity [19]. 
Phytoestrogens exert a dose-dependent effect on osteoblasts and 
osteoprogenitor cells, stimulating osteogenesis at low concentrations 
while inhibiting it at high doses [20]. Wattel [18] has reported that 
quercetin and kaempferol flavonoids optimally worked at varying doses. 
Various flavonoids are present in C. asiatica, such as quercetin, rutin, 
naringin, kaempferol, and catechins, but not all are effective due to their 
dose-dependent properties. Each type of phytoestrogen has a complex 
and specific action at different optimal doses [21]. Osteoclasts may have 
shown significant results because they take only 3 weeks to complete 
bone resorption, and many studies have shown that phytoestrogens 
function by inhibiting osteoclast formation and activity [20].
The results of statistical analysis showed that the correlation between 
increased C. asiatica leaf extract dose and osteocyte number in Wistar 
rats was strong and significant. The correlation direction was positive, 
indicating that greater the dose of C. asiatica leaf extract, greater 
would be the number of osteocytes in Wistar rats. Perhaps, increased 
osteocyte numbers maintain systemic mineral homeostasis in the 
body. Apparently, the ability to modify osteocyte formation facilitates 
the regulation of osteoblast function in bone disease, particularly 
osteoporosis. In addition, the increased number of osteocytes, 
increased osteogenesis by osteoblasts was expected in this study. The 
previous research has shown that strategies targeting the regulation 
of osteocyte function and its effect on osteoblast cell behavior are 
effective in reversing the process of decrease in bone mass with aging, 
thereby controlling osteogenic processes [22]. Therefore, angiotensin 
is expected to promote osteogenesis and helps to prevent osteoporosis.
The pharmacokinetics of phytoestrogens from C. asiatica could be 
influenced by other factors such as the duration of extract storage 
or the effect of other chemical constituents of C. asiatica on the rats 
that have not yet been studied. This proves that the administration of 
C. asiatica leaf extract at a dose of 180 mg/kg BW could increase the 
number of osteocytes in the tibia of ovariectomized Wistar rats at risk 
of osteoporosis.
Finally, C. asiatica extract administration could reduce the number 
of osteoclasts formed during the process of tibia bone destruction in 
rats due to the action of flavonoids such as the phytoestrogens and 
antioxidants, which can reduce oxidative stress. However, the extract 
administration did not increase the number of osteoblasts. Further, 
research is warranted to determine whether different doses of C. asiatica 
leaf extract can confer a preventive effect against osteoporosis in a 
larger patient cohort over a longer study duration (>3 months).
Natural products offer a rich source of structurally diverse substances 
with a wide range of biological activities, which could be useful 
for the development of alternative or adjunctive for osteoporosis 
therapies [23]. The market for anti-aging products is also growing 
gradually, and customers are aware of active principles in the 
cosmetics [24]. C. asiatica as natural product also can be an alternative 
treatment for osteoporosis in aging women.
CONCLUSION
This experimental study demonstrated that the administration of 
C. asiatica leaf extract at doses of 60 mg/kg BW and 120 mg/kg BW 
significantly decreased the number of osteoclasts in ovariectomized 
rats. However, the administration of C. asiatica leaf extract did not 
significantly increase the number of osteoblasts. Furthermore, the 
administration of C. asiatica leaf extract at a dose of 180 mg/kg BW 
significantly increased the number of osteocytes following ovariectomy.
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